Peter Van Vlasselaer

Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

Vivian Barry-Hamilton, Rhyannon Spangler, Derek Marshall et al. · Nature Medicine · 2010 · 841 citations

Redox Signaling, Allosteric Inhibition, Lysyl Oxidase–like-2 Impedes +7

Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways

Hugues Gascan, J F Gauchat, Gregorio Aversa et al. · The Journal of Immunology · 1991 · 268 citations · Full text

PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients

Aung Naing, Jeffrey R. Infante, Kyriakos P. Papadopoulos et al. · Cancer Cell · 2018 · 239 citations · Full text

Cancer Immunosurveillance, Autoimmune Disease, Immunology +10

Transforming growth factor-beta directs IgA switching in human B cells

Peter Van Vlasselaer, Juha Punnonen, J E de Vries · The Journal of Immunology · 1992 · 231 citations

Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors

Aung Naing, Kyriakos P. Papadopoulos, Karen A. Autio et al. · Journal of Clinical Oncology · 2016 · 211 citations · Full text

Cancer Immunosurveillance, Antitumor Activity, Immune Activation +15